Details

Product Name in the RMS: Bortezomib LOGENEX

MR Number: NO/H/0244/001
Date of outcome: 12.06.2015

Type of application
Level 1: Level 2: Level 3: Level 4: Level 5:	Known Active Substance Initial Application Generic Chemical Substance Prescription Only
Active Substances	BORTEZOMIB 3,5 mg
Form	POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION/INFUSION
MA Holder in the RMS	LOGENEX Pharm GmbH
RMS	Norway
Date of last change	12.01.2020
ATC-Code	L01XX32 Bortezomib

CMS Country	Domestic Product Name
Austria
Belgium	Bortezomib B-Medical 3,5mg poeder voor oplossing voor injectie
Croatia	Bortezomib Alpha-Medical 3,5 mg prašak za otopinu za injekciju
Cyprus	Bortezomib Ledpharm 3.5mg powder for solution for injection
Germany	Bortezomib Ribosepharm 3,5 mg Pulver zur Herstellung einer Injektionslösung
Iceland	Bortezomib W&H 3,5 mg stungulyfsstofn, lausn
Italy
Latvia	Bortezomib PharmIdea 3,5 mg pulveris injekciju šķīduma pagatavošanai
Netherlands
Portugal
Slovak Republic	Bortezomib Pharmevid 3,5 mg prášok na injekčný roztok
Spain

Documents
PAR:	NO_H_0244_001_PAR.pdf (15.10.2019)
PARSummary:	NO_H_0244_001_PARSummary.pdf (15.10.2019)